Lina van der Straten

Lina van der Straten is a Researcher at Erasmus MC in the Department of Internal Medicine, with a focus on chronic lymphocytic leukemia (CLL) research. Her work spans epidemiological studies, molecular biology, and translational research in hematological malignancies. She completed her doctoral thesis in 2024 titled The Epidemiology and Molecular Aspects of Chronic Lymphocytic Leukemia: A lifelong journey, analyzing CLL's natural history and molecular drivers. Her research emphasizes population-based studies, genetic biomarkers, and clinical outcomes in CLL patients.

Key research interests include CLL mortality patterns, second primary malignancies, and proteomic biomarkers for treatment-free survival. She collaborates internationally on projects exploring genetic drivers of leukemia development and molecular mechanisms in B-cell malignancies. Notable contributions include identifying THEMIS2 as a prognostic biomarker and elucidating genetic changes 16 years prior to CLL diagnosis.